Sponsored Links
| Eisai Receives Complete Response Letter From FDA For Rabeprazole Sodium Extended-Release Capsules, 50 Mg For GERD |
 |
 |
 |
| Medical News - Acid Reflux and GERD | |||
|
Eisai announced that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroeso... Read more: Acid Reflux / GERD News From Medical News Today
|